Subscribe to RSS
DOI: 10.1055/s-0028-1083821
© Georg Thieme Verlag KG Stuttgart · New York
Excessive Talking Triggered by Methylphenidate in a Boy with ADHD
Publication History
received 13.03.2008
revised 13.05.2008
accepted 02.06.2008
Publication Date:
19 January 2009 (online)

There has previously been no report of provocation of excessive talking as an adverse effect of methylphenidate (MPH) in children with ADHD. This is a report of excessive talking after taking methylphenidate in a child with ADHD, diagnosed according to DSM-IV diagnostic criteria using the bFarsi version of KSADS. His mother and nursery teacher reported a significant increase of talking about 45 min after taking medication. They scored hypertalking as 7–9 on a 1–10 visual analogue scale. There were no symptoms of affective or anxiety disorder. Re-challenge was conducted many times and hypertalking reoccurred after every time he took the medication. It is possible that MPH increases verbal output in some ADHD children.
References
- 1 Attalah MM, Saied MM, Yahya R. et al . Ketamine anesthesia for short transurethral urologic procedures. Middle East J Anesthesiol. 1993; 12 123-133
- 2 Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366 237-248
- 3 Bilder RM, Lieberman JA, Kim Y. et al . Methylphenidate and neuroleptic effects on oral word production in schizophrenia. Neuropsychiat Neuropsychol Behav Neurol. 1992; 5 262-271
-
4 Douglas VI. Cognitive control processes in attention-deficit hyperactivity disorder. In: Quay HC, Hogan AE, eds.
Handbook of Disruptive Behavior Disorders . Plenum Press, New York 1999: 105-138 - 5 Ghanizadeh A, Mohammadi MR, Yazdanshenas A. Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. BMC Psychiatry. 2006; 15 10
- 6 Kim EY, Miklowitz DJ. Childhood mania, attentiondeficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disord. 2002; 4 215-225
- 7 O’Driscoll GA, Dépatie L, Holahan AL. et al . Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57 1452-1460
- 8 Pietrzak RH, Mollica CM, Maruff P. et al . Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2006; 30 1225-1245
- 9 Pliszka SR. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry. 2005; 57 1385-1390
- 10 Shafritz KM, Marchione KE, Gore JC. et al . The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am J Psychiatry. 2004; 161 1990-1997
- 11 Szeszko PR, Bilder RM, Dunlop JA. et al . Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases. Biol Psychiatry. 1999; 45 680-686
Correspondence
Prof. A. GhanizadehMD
Department of Psychiatry
Hafez Hospital
Shiraz
Iran
Fax: +98/711/627 93 19
Email: ghanizad@sina.tums.ac.ir
Email: ghanizadeha@hotmail.com